Download PDF
Synlett 2009(5): 787-789  
DOI: 10.1055/s-0028-1087940
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Azide-Free Synthesis of Oseltamivir from l-Methionine

Tetsuta Oshitari, Tadakatsu Mandai*
Department of Life Science, Kurashiki University of Science & the Arts, 2640, Nishinoura, Tsurajima, Kurashiki 712-8505, Japan
Fax: +81(86)4401062; e-Mail: ted@chem.kusa.ac.jp;
Further Information

Publication History

Received 11 December 2008
Publication Date:
09 March 2009 (online)

    Permissions and Reprints All articles of this category

Abstract

Highly enantioselective synthesis of oseltamivir has been achieved starting from l-methionine, in which Staudinger ­reaction is utilized for the alignment of three contiguous chiral centers of oseltamivir. The present method would lead to an alternative synthesis of oseltamivir that avoids the use of hazardous azide reagents.

Key words

anti-influenza drugs - tamiflu - Staudinger reaction - ­hydroformylations - intramolecular aldol condensation

    References and Notes

  • 2 Kim CU. Lew W. Williams MA. Liu H. Zhang L. Swaminathan S. Bischofberger N. Chen MS. Mendel DB. Tai CY. Laver WG. Stevens RC. J. Am. Chem. Soc.  1997,  119:  681 
    CrossrefPubMedGoogle Scholar
  • 3 Farina V. Brown JD. Angew. Chem. Int. Ed.  2006,  45:  7330 
    CrossrefPubMedGoogle Scholar
  • 4a Yeung Y.-Y. Hong S. Corey EJ. J. Am. Chem. Soc.  2006,  128:  6310 
    Google Scholar
  • 4b Fukuta Y. Mita T. Fukuda N. Kanai M. Shibasaki M. J. Am. Chem. Soc.  2006,  128:  6312 
    Google Scholar
  • 4c Cong X. Yao ZJ. J. Org. Chem.  2006,  71:  5365 
    Google Scholar
  • 4d Mita T. Fukuda N. Roca FX. Kanai M. Shibasaki M. Org. Lett.  2007,  9:  259 
    Google Scholar
  • 4e Yamatsugu K. Kamijo S. Suto Y. Kanai M. Shibasaki M. Tetrahedron Lett.  2007,  48:  1403 
    Google Scholar
  • 4f Bromfield KM. Graden H. Hagberg DP. Olsson T. Kann N. Chem. Commun.  2007,  3183 
    Google Scholar
  • 4g Satoh N. Akiba T. Yokoshima S. Fukuyama T. Angew. Chem. Int. Ed.  2007,  46:  5734 
    Google Scholar
  • 4h Shie J.-J. Fang J.-M. Wang S.-Y. Tsai K.-C. Cheng Y.-SE. Yang A.-S. Hsiao S.-C. Su C.-Y. Wong C.-H. J. Am. Chem. Soc.  2007,  129:  11892 
    Google Scholar
  • 4i Trost BM. Zhang T. Angew. Chem. Int. Ed.  2008,  47:  1 
    Google Scholar
  • 4j Zutter U. Iding H. Spurr P. Wirz B. J. Org. Chem.  2008,  73:  4895 
    Google Scholar
  • 4k Shie J.-J. Fang J.-M. Wong C.-H. Angew. Chem. Int. Ed.  2008,  47:  5788 
    Google Scholar
  • 4l Satoh N. Akiba T. Yokoshima S. Fukuyama T. Tetrahedron  2009,  in press
    Google Scholar
  • 4m Yamatsugu K. Yin L. Kamijo S. Kimura Y. Kanai M. Shibasaki M. Angew. Chem. Int. Ed.  2009,  48:  1070 
    Google Scholar
  • 4n Ishikawa H. Suzuki T. Hayashi Y. Angew. Chem. Int. Ed.  2009,  48:  1304 
    Google Scholar
  • 5 For a recent review on the synthesis of oseltamivir (1), see: Shibasaki M. Kanai M. Eur. J. Org. Chem.  2008,  1839 ; see also ref. 3
    CrossrefGoogle Scholar
  • 6 Mandai T. Oshitari T. Synlett  2009,  783 
    Article in Thieme ConnectGoogle Scholar
  • For previously reported azide-free syntheses, see:
  • 7a Karpf M. Trussardi R. J. Org. Chem.  2001,  66:  2044 
    Google Scholar
  • 7b Harrington PJ. Brown JD. Foderaro T. Hughes RC. Org. Process Res. Dev.  2004,  8:  86 
    Google Scholar
  • For preparation of cis-β-lactams, see:
  • 8a Palomo C. Cabré F. Ontoria JM. Tetrahedron Lett.  1992,  33:  4819 
    Google Scholar
  • 8b Palomo C. Cossío FP. Cuevas C. Lecea B. Mielgo A. Román P. Luque A. Martinez-Ripoll M. J. Am. Chem. Soc.  1992,  114:  9360 
    Google Scholar
  • For reviews of Staudinger reaction, see:
  • 9a Palomo C. Aizpurua JM. Ganboa I. Oiarbide M. Eur. J. Org. Chem.  1999,  3223 
    Google Scholar
  • 9b Palomo C. Aizpurua JM. Ganboa I. Oiarbide M. Curr. Med. Chem.  2004,  11:  1837 
    Google Scholar
  • For reviews of β-lactams as chiral synthetic building blocks, see:
  • 10a Alcaide B. Almendros P. Curr. Med. Chem.  2004,  11:  1921 
    Google Scholar
  • 10b Alcaide B. Almendros P. Aragoncillo C. Chem. Rev.  2007,  107:  4437 
    Google Scholar
  • 11 Wallace GA. Scott RW. Heathcock CH. J. Org. Chem.  2000,  65:  4145 
    CrossrefGoogle Scholar
  • A mixture of 7b (1.55 g, ca. 3.22 mmol), NaHCO3 (2.70 g, 32.2 mmol), α-pinene (10 mL), and decalins (10 mL) was placed into a 100 mL round-bottomed flask fitted with a reflux condenser. The reaction mixture was deoxygenated by alternate evacuation-argon flush cycles (five iterations) and heated with vigorous stirring at 150-155 ˚C for 6 h under argon atmosphere. After being cooled to r.t., the reaction mixture was partitioned between H2O (30 mL) and EtOAc (30 mL). The organic layer separated was washed with brine (2 × 30 mL), dried (MgSO4), filtered, and concentrated in vacuo. The residue was purified by flash column chromatography (hexane-EtOAc, 1:0 to 20:1 to 10:1 to 6:1) to give olefin 8a as a white solid (1.09 g, 81% from 7a); [α]D ²6 -93.6 (c 1.03, CHCl3); mp 116.9-117.4 ˚C. ¹H NMR (500 MHz, CDCl3): δ = 7.35 (d, J = 8.8 Hz, 2 H), 6.87 (d, J = 8.8 Hz, 2 H), 5.92 (ddd, J = 7.6, 10.4, 17.0 Hz, 1 H), 5.30 (d, J = 9.5 Hz, 1 H), 5.07 (d, J = 10.4 Hz, 1 H), 5.00 (d, J = 17.0 Hz, 1 H), 4.94 (m, 1 H), 4.78 (d, J = 5.5 Hz, 1 H), 4.38 (dd, J = 5.1, 5.5 Hz, 1 H), 3.79 (s, 3 H), 3.60 (tt, J = 5.5, 5.5 Hz, 1 H), 1.72 (m, 2 H), 1.62 (m, 2 H), 1.45 (br s, 9 H), 0.95 (t, J = 7.5 Hz, 6 H). ¹³C NMR (125 MHz, CDCl3): δ = 165.2, 156.4, 133.8, 130.7, 118.6, 114.5, 106.3, 84.4, 81.0, 79.7, 57.5, 55.5, 52.3, 28.4, 26.5, 25.5, 9.6, 9.3. For thermal elimination of a methionine-derived sulfoxide, see:
  • 14a Ohfune Y. Kurokawa N. Tetrahedron Lett.  1984,  25:  1071 
    Google Scholar
  • 14b For our previous protocol of thermal desulfinylation, see also: Mandai T. Matsumoto S. Kohama M. Kawada M. Tsuji J. Saito S. Moriwake T. J. Org. Chem.  1990,  55:  5671 
    Google Scholar
  • 16 Kronenthal DR. Han CY. Taylor MK. J. Org. Chem.  1982,  47:  2765 
    CrossrefGoogle Scholar
  • 17 Cuny GD. Buchwald SL. J. Am. Chem. Soc.  1993,  115:  2066 
    CrossrefGoogle Scholar
  • 6,6′-{[3,3′-bis(1,1-dimethylethyl)-5,5′-dimethoxy[1,1′-biphenyl]-2,2′-diyl]bis(oxy)}bis{dibenzo[d,f][1,3,2]dioxa-phosphepine}:
  • 18a Billig E, Abatjoglou AG, and Bryant DR. inventors; US  4668651. 
    Google Scholar
  • 18b Billig E, Abatjoglou AG, and Bryant DR. inventors; US  4769498.  ; for preparation of BIPHEPHOS, see Supporting Information of ref. 17
    Google Scholar
  • 19 Fukuyama T. Lin S.-C. Li L. J. Am.Chem. Soc.  1990,  112:  7050 
    CrossrefGoogle Scholar
  • 20a Corey EJ. Danheiser RL. Chandrasekaran S. Siret P. Keck GE. Gras J.-L. J. Am. Chem. Soc.  1978,  100:  8031 
    Google Scholar
  • 20b Snyder SA. Corey EJ. Tetrahedron Lett.  2006,  47:  2083 
    Google Scholar
1

Present address: School of Pharmaceutical Sciences, Teikyo University, 1091-1 Suarashi, Sagamiko, Sagamihara, 229-0195, Japan.

12

The desired cis-β-lactam 7a was easily purified by trituration in cold MeOH to remove byproducts such as minor stereoisomers (ca. 5%) and N-(4-methoxyphenyl)-
(3-pentyloxy)acetamide.
Compound 7a: a white solid; [α]D ²² -119 (c 0.99 CHCl3); mp 161.6-162.6 ˚C. ¹H NMR (500 MHz, CDCl3): δ = 7.39 (br d, J = 8.9 Hz, 2 H), 6.87 (br d, J = 8.9 Hz, 2 H), 5.09 (br d, J = 10.1 Hz, 1 H), 4.78 (d, J = 5.5 Hz, 1 H), 4.56 (m, 1 H), 4.40 (dd, J = 5.5, 5.8 Hz, 1 H), 3.79 (s, 3 H), 3.61 (tt, J = 5.8, 5.8 Hz, 1 H), 2.55 (ddd, J = 4.6, 8.6, 13.1 Hz, 1 H), 2.38 (ddd, J = 7.9, 8.3, 13.1 Hz, 1 H), 1.93 (m, 1 H), 1.87 (s, 3 H), 1.80 (m, 1 H), 1.72 (m, 2 H), 1.62 (m, 2 H), 1.51-1.43 (two br s, 9 H), 1.94 (m, 6 H). ¹³C NMR (125 MHz, CDCl3): δ = 165.3, 156.6, 155.7, 130.6, 118.4, 114.6, 84.5, 81.1, 79.6, 57.3, 55.5, 48.7, 30.9, 28.8, 28.4, 26.6, 25.5, 15.2, 9.6, 9.4. Anal. Calcd for C24H38N2O5S: C, 61.77; H, 8.21; N, 6.00. Found: C, 61.87; H, 8.31; N, 6.16.

13

Daicel CHIRALCEL OD-RH; eluent: MeCN-H2O (10:1); λ = 254 nm; flow rate: 0.3 mL/min; t R(7a) = 7.8 min; t R (ent-7a) = 9.9 min.

15

Compound 8c: white solid; [α]D ²5 -14.4 (c 0.86 CHCl3); mp 111.6-111.8 ˚C. ¹H NMR (500 MHz, CDCl3): δ = 7.60-7.55 (br s, 4 H), 6.96 (d, J = 8.8 Hz, 2 H), 6.39 (d, J = 8.8 Hz, 2 H), 6.20 (ddd, J = 6.1, 10.0, 17.0 Hz, 1 H), 5.33-5.26 (m, 3 H), 5.03 (dd, J = 5.2, 10.3 Hz, 1 H), 4.89 (d, J = 5.2 Hz, 1 H), 3.65 (tt, J = 5.5, 5.5 Hz, 1 H), 3.45 (s, 3 H), 1.72 (m, 2 H), 1.61 (m, 2 H), 1.02 (t, J = 7.5 Hz, 3 H), 0.92 (t, J = 7.5 Hz, 3 H). ¹³C NMR (125 MHz, CDCl3): δ = 167.8, 166.0, 156.9, 134.2, 133.5, 131.7, 131.4, 128.1, 123.5, 122.8, 122.7, 119.0, 118.5, 114.5, 113.8, 83.3, 80.3, 57.3, 55.1, 53.0, 26.2, 25.3, 9.4, 9.2. Anal. Calcd for C26H28N2O5: C, 69.63, H, 6.29, N, 6.25. Found: C, 69.25; H, 6.10; N, 6.29.

21

Compound 12: off-white solid; [α]D ²³.4 -44.0 (c 1.05, CHCl3); mp 198-199.1 ˚C. ¹H NMR (500 MHz, CDCl3, data of a mixture of rotamers): δ = 9.56 (s, 0.15 H), 9.54 (s, 0.85 H), 7.86-7.72 (m, 4 H), 6.68 (s, 0.15 H), 6.67 (s, 0.85 H), 5.58 (d, J = 7.6 Hz, 0.85 H), 5.26 (d, J = 7.6 Hz, 0.15 H), 4.95-4.87 (m, 0.85 H), 4.75-4.71 (m, 0.85 H), 4.50-4.32 (m, 1.15 H), 4.15-4.10 (m, 0.15 H), 3.46-3.33 (m, 1 H), 3.10-2.97 (m, 1 H), 2.76-2.65 (m, 1 H), 2.05 (s, 0.45 H), 1.78 (s, 2.55 H), 1.60-1.50 (m, 4 H), 1.00-0.85 (m, 6 H). ¹³C NMR (125 MHz, CDCl3, data of a mixture of rotamers): δ = 192.2, 170.3, 168.1, 147.5, 138.8, 134.2, 131.6, 123.4, 82.4, 74.6, 54.3, 47.8, 26.3, 25.7, 25.5, 23.3, 9.6, 9.3. Anal. Calcd for C22H26N2O5: C, 66.32, H, 6.58, N, 7.03. Found: C, 66.06; H, 6.72; N, 6.98.